Cipla Launches India’s First Inhalable Insulin, Afrezza

ANS: Cipla has introduced Afrezza, India’s first inhalable insulin, following approval from the Central Drugs Standard Control Organisation (CDSCO). Developed by MannKind Corporation in the …